- Home
- RNAC vs ATRO Comparison
RNAC vs ATRO Comparison
Compare RNAC & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- ATRO
- Stock Information
- Founded
- RNAC 2007
- ATRO 1968
- Country
- RNAC United States
- ATRO United States
- Employees
- RNAC N/A
- ATRO N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- RNAC Health Care
- ATRO Industrials
- Exchange
- RNAC Nasdaq
- ATRO Nasdaq
- Market Cap
- RNAC 460.7M
- ATRO 864.1M
- IPO Year
- RNAC 2016
- ATRO N/A
- Fundamental
- Price
- RNAC $16.61
- ATRO $24.23
- Analyst Decision
- RNAC Strong Buy
- ATRO Hold
- Analyst Count
- RNAC 8
- ATRO 1
- Target Price
- RNAC $41.67
- ATRO $23.00
- AVG Volume (30 Days)
- RNAC 69.8K
- ATRO 633.7K
- Earning Date
- RNAC 05-07-2025
- ATRO 03-04-2025
- Dividend Yield
- RNAC N/A
- ATRO N/A
- EPS Growth
- RNAC N/A
- ATRO N/A
- EPS
- RNAC N/A
- ATRO N/A
- Revenue
- RNAC $38,913,000.00
- ATRO $795,426,000.00
- Revenue This Year
- RNAC N/A
- ATRO $7.40
- Revenue Next Year
- RNAC $60.00
- ATRO $5.77
- P/E Ratio
- RNAC N/A
- ATRO N/A
- Revenue Growth
- RNAC 49.64
- ATRO 15.41
- 52 Week Low
- RNAC $11.67
- ATRO $14.13
- 52 Week High
- RNAC $41.87
- ATRO $25.54
- Technical
- Relative Strength Index (RSI)
- RNAC 35.72
- ATRO 76.04
- Support Level
- RNAC $17.08
- ATRO $23.65
- Resistance Level
- RNAC $18.80
- ATRO $25.54
- Average True Range (ATR)
- RNAC 1.06
- ATRO 1.01
- MACD
- RNAC -0.14
- ATRO 0.31
- Stochastic Oscillator
- RNAC 10.80
- ATRO 78.63
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.